Literature DB >> 26081871

Promoter methylation-independent reactivation of PAX1 by curcumin and resveratrol is mediated by UHRF1.

Gaurav Parashar1, Neena Capalash2.   

Abstract

Paired box gene1 (PAX1) is essential for normal chordate development and has been recently characterised to be a tumour suppressor gene which is frequently hypermethylated in different cancer types. We investigated the reactivation of PAX1 using curcumin and resveratrol in HeLa, SiHa and Caski cell lines and role of hypermethylation in 39 CpG sites of PAX1 promoter from -6 to -286 region in regulating its expression. Curcumin in HeLa and SiHa cells and resveratrol in Caski cells caused significant (P < 0.01) reactivation of PAX1 expression as shown by qRT PCR, but reversal of promoter hypermethylation was not observed across the three cell lines. Interestingly, even positive control 5-aza-2'-deoxycytidine was not found to be effective to cause demethylation of CpG sites under consideration suggesting the promoter region to be resistant towards hypomethylating effects as shown by bisulphite sequencing. However, a striking correlation between PAX1 reactivation and Ubiquitin-like with PHD and RING finger domains 1 (UHRF1) downregulation after treatment with curcumin and resveratrol in HeLa, SiHa and Caski cell lines was observed which was further confirmed after transient silencing of UHRF1 expression. PAX1 reexpression was also obtained in Caski and SiHa cell lines after treatment with sodium butyrate, a histone deacetylase inhibitor, suggesting that PAX1 reactivation by curcumin and resveratrol may be due to their effect on histone deacetylase mediated through downregulation of UHRF1 which can regulate both DNA methylation and histone acetylation.

Entities:  

Keywords:  Curcumin; HDAC; Hypomethylation; PAX1; Resveratrol; UHRF1

Mesh:

Substances:

Year:  2015        PMID: 26081871     DOI: 10.1007/s10238-015-0366-1

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  30 in total

1.  Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells.

Authors:  Barbara Stefanska; Karolina Rudnicka; Andrzej Bednarek; Krystyna Fabianowska-Majewska
Journal:  Eur J Pharmacol       Date:  2010-05-03       Impact factor: 4.432

Review 2.  Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.

Authors:  Mahmoud Alhosin; Tanveer Sharif; Marc Mousli; Nelly Etienne-Selloum; Guy Fuhrmann; Valérie B Schini-Kerth; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2011-04-15

Review 3.  Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis.

Authors:  Christian Bronner; Mounira Krifa; Marc Mousli
Journal:  Biochem Pharmacol       Date:  2013-10-14       Impact factor: 5.858

4.  Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell line.

Authors:  Gaurav Parashar; Nidarshana Chaturvedi Parashar; Neena Capalash
Journal:  Mol Cell Biochem       Date:  2012-06       Impact factor: 3.396

5.  Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs.

Authors:  Hyun-Jung Kim; Suk-Chul Bae
Journal:  Am J Transl Res       Date:  2010-12-26       Impact factor: 4.060

6.  An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.

Authors:  Her-Young Su; Hung-Cheng Lai; Ya-Wen Lin; Yu-Ching Chou; Chin-Yu Liu; Mu-Hsien Yu
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

7.  Pax1 acts as a negative regulator of chondrocyte maturation.

Authors:  Aki Takimoto; Hiromi Mohri; Chikara Kokubu; Yuji Hiraki; Chisa Shukunami
Journal:  Exp Cell Res       Date:  2013-09-27       Impact factor: 3.905

8.  Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma.

Authors:  V Greger; N Debus; D Lohmann; W Höpping; E Passarge; B Horsthemke
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

9.  Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.

Authors:  Nataša Vasiljević; Dorota Scibior-Bentkowska; Adam R Brentnall; Jack Cuzick; Attila T Lorincz
Journal:  Gynecol Oncol       Date:  2014-02-06       Impact factor: 5.482

10.  Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.

Authors:  Rafael Guerrero-Preston; Christina Michailidi; Luigi Marchionni; Curtis R Pickering; Mitchell J Frederick; Jeffrey N Myers; Srinivasan Yegnasubramanian; Tal Hadar; Maartje G Noordhuis; Veronika Zizkova; Elana Fertig; Nishant Agrawal; William Westra; Wayne Koch; Joseph Califano; Victor E Velculescu; David Sidransky
Journal:  Epigenetics       Date:  2014-05-01       Impact factor: 4.528

View more
  13 in total

1.  The combination of dimethoxycurcumin with DNA methylation inhibitor enhances gene re-expression of promoter-methylated genes and antagonizes their cytotoxic effect.

Authors:  Hazem E Hassan; Jean-Arnaud Keita; Lawrence Narayan; Sean M Brady; Richard Frederick; Samuel Carlson; Karen C Glass; Senthil Natesan; Thomm Buttolph; Tamer E Fandy
Journal:  Epigenetics       Date:  2016-11-01       Impact factor: 4.528

2.  Aerosol Delivery of Curcumin Reduced Amyloid-β Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease.

Authors:  Richard McClure; Henry Ong; Vaibhab Janve; Shawn Barton; Meiying Zhu; Bo Li; Mary Dawes; W Gray Jerome; Adam Anderson; Pierre Massion; John C Gore; Wellington Pham
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Aberrant Epigenetic Alteration of PAX1 Expression Contributes to Parathyroid Tumorigenesis.

Authors:  Priyanka Singh; Sanjay Kumar Bhadada; Ashutosh Kumar Arya; Uma Nahar Saikia; Naresh Sachdeva; Divya Dahiya; Jyotdeep Kaur; Maria Luisa Brandi; Sudhaker Dhanwada Rao
Journal:  J Clin Endocrinol Metab       Date:  2022-01-18       Impact factor: 6.134

Review 4.  The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions.

Authors:  Abdelhakim Bouyahya; Hamza Mechchate; Loubna Oumeslakht; Ikrame Zeouk; Sara Aboulaghras; Abdelaali Balahbib; Gokhan Zengin; Mohammad Amjad Kamal; Monica Gallo; Domenico Montesano; Nasreddine El Omari
Journal:  Biomolecules       Date:  2022-02-25

5.  Real-time colorimetric detection of DNA methylation of the PAX1 gene in cervical scrapings for cervical cancer screening with thiol-labeled PCR primers and gold nanoparticles.

Authors:  Jin Huang; Yu-Ligh Liou; Ya-Nan Kang; Zhi-Rong Tan; Ming-Jing Peng; Hong-Hao Zhou
Journal:  Int J Nanomedicine       Date:  2016-10-12

Review 6.  Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer.

Authors:  Mahmoud Alhosin; Ziad Omran; Mazin A Zamzami; Abdulrahman L Al-Malki; Hani Choudhry; Marc Mousli; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2016-11-14

7.  – (-) Menthol Induces Reversal of Promoter Hypermethylation and Associated Up-Regulation of the FANCF Gene in the SiHa Cell Line

Authors:  Gaurav Parashar; Nidarshana Chaturvedi Parashar; Neena Capalash
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

Review 8.  The promising role of PAX1 (aliases: HUP48, OFC2) gene methylation in cancer screening.

Authors:  Chao Fang; Sai-Ying Wang; Yu-Ligh Liou; Ming-Hua Chen; Wen Ouyang; Kai-Ming Duan
Journal:  Mol Genet Genomic Med       Date:  2019-01-12       Impact factor: 2.183

9.  Discovery of small molecules targeting the tandem tudor domain of the epigenetic factor UHRF1 using fragment-based ligand discovery.

Authors:  Lyra Chang; James Campbell; Idris O Raji; Shiva K R Guduru; Prasanna Kandel; Michelle Nguyen; Steven Liu; Kevin Tran; Navneet K Venugopal; Bethany C Taylor; Matthew V Holt; Nicolas L Young; Errol L G Samuel; Prashi Jain; Conrad Santini; Banumathi Sankaran; Kevin R MacKenzie; Damian W Young
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

10.  Sodium Butyrate Enhances Curcuminoids Permeability through the Blood-Brain Barrier, Restores Wnt/β-Catenin Pathway Antagonists Gene Expression and Reduces the Viability of Glioblastoma Cells.

Authors:  Aleksandra Majchrzak-Celińska; Robert Kleszcz; Anna Stasiłowicz-Krzemień; Judyta Cielecka-Piontek
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.